Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sunshine Biopharma, Inc. (SBFM) had Receiveable Turnover of 9.44 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$24.09M |
|
$-4.51M |
|
$15.75M |
|
$8.34M |
|
$28.88M |
|
$-4.79M |
|
$0.67M |
|
$-4.11M |
|
$-4.11M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.79M |
|
$-4.64M |
|
24.33M |
|
24.33M |
|
$-0.19 |
|
$-0.19 |
|
Balance Sheet Financials | |
$24.89M |
|
$0.37M |
|
$2.46M |
|
$27.35M |
|
$5.55M |
|
-- |
|
$0.59M |
|
$6.14M |
|
$21.21M |
|
$19.76M |
|
$21.21M |
|
28.02M |
|
Cash Flow Statement Financials | |
$-8.78M |
|
$-0.66M |
|
$3.43M |
|
$21.83M |
|
$16.29M |
|
$-5.53M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
34.61% |
|
-19.86% |
|
-19.86% |
|
-19.24% |
|
-17.06% |
|
-18.70% |
|
$-8.86M |
|
-- |
|
-- |
|
-- |
|
0.88 |
|
2.75 |
|
Receiveable Turnover |
9.44 |
38.67 |
|
-21.25% |
|
-22.80% |
|
-16.48% |
|
-21.25% |
|
$0.76 |
|
$-0.36 |
|
$-0.36 |